MedReg Intel

ISO 13485 for Medical Device Startups What Actually Matters (And What Doesn’t) By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Most medical device startups misunderstand ISO 13485. They treat it as: A certificate to obtain A compliance checkbox A consultant-driven documentation exercise But ISO 13485 is not a certificate. It is a system for building controlled, traceable, defensible medical devices . And for startups operating under MDR 2017 in India , it is not optional thinking. Why ISO 13485 Matters for Startups Even if you are early-stage, ISO 13485 influences: Regulatory approval timelines CDSCO confidence Investor trust Product consistency Risk management maturity ⚠️ Common Founder Mistake Waiting until “just before submission” to implement ISO 13485. By then, design decisions are already undocumented. What ISO 13485 Is (Practically) ISO 13485 is a Quality Management System (QMS) standard tailored for medical devices. ...

Medical Device Classification in India Class A, B, C & D — Practically Explained Under MDR 2017 By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Medical device classification in India is not paperwork. It is the single decision that determines: Your regulatory pathway Your documentation burden Your clinical evidence requirements Your approval timelines Your compliance cost Under the Medical Device Rules (MDR), 2017 , every medical device is classified into Class A, B, C, or D based on risk. Misclassify your device — and everything downstream becomes unstable. This article explains classification practically , not just legally. Why Classification Matters More Than You Think Your classification affects: Whether you apply to State or Central authority Which forms you submit (MD-5, MD-9, MD-14, etc.) Whether clinical investigation is required How intense CDSCO scrutiny will be Post-market obligations ⚠️ Common Founder Mistake...

Why CDSCO Rejects Medical Device Applications in India The Real Reasons — And How to Avoid Costly Delays By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Medical device applications in India are not rejected randomly. They are rejected predictably. Most rejections under the Medical Device Rules (MDR) 2017 are not due to technological flaws or innovation gaps. They occur because of documentation inconsistency, regulatory misinterpretation, or process discipline failures . Understanding why CDSCO rejects applications is not about fear — it is about preparation. This article explains the real scrutiny patterns , the most common rejection triggers, and how serious teams avoid them. Why This Matters A rejected application can: Delay market entry by months Trigger costly rework Block customs clearance Damage regulatory credibility Increase investor anxiety Most of this is preventable. The Most Common Reasons CDSCO Rejects Applicati...

A Practical Roadmap for Developing Medical Devices in India From Idea to Market — Without Costly Regulatory Mistakes By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Developing a medical device in India is not just an engineering challenge. It is a regulatory, clinical, manufacturing, and ethical journey — and most failures happen not because the product is bad, but because the roadmap is wrong . Too many teams build first and think about regulation later. By the time CDSCO enters the picture, timelines are already broken. This guide lays out a clear, India-specific roadmap for medical device development — grounded in MDR 2017, CDSCO scrutiny patterns, and real-world failures — so teams can build right , not just fast. Why This Matters An incorrect development sequence can: Delay approvals by months Multiply compliance costs Force redesigns late in the lifecycle Undermine regulatory credibility Most of this is preventable —...